Table 2.
Elicited prior means of FR(t | τ) and FT (t | τ) for the autologous stem cell transplantation trial to optimize (schedule, dose) of melphalan. For each total dose d, the prior means for the regimes τ = (−2, d) and τ = ((−3, −2), d) were identical.
| Days of Follow up | Prior Means of FR(t | τ)
|
Prior Means of FT (t | τ)
|
||||
|---|---|---|---|---|---|---|
| Total dose of Melphalan (mg/m2) | Total dose of Melphalan (mg/m2) | |||||
| d = 140 | d = 180 | d = 200 | d = 140 | d = 180 | d = 200 | |
|
|
|
|
||||
| t = 1 | – | – | – | .01 | .02 | .03 |
| t = 3 | – | – | – | .05 | .07 | .09 |
| t = 6 | – | – | – | .15 | .18 | .20 |
| t = 10 | – | – | – | .25 | .30 | .32 |
| t = 14 | – | – | – | .30 | .35 | .40 |
| t = 28 | – | – | – | .33 | .38 | .43 |
| t = 30 | .05 | .08 | .10 | – | – | – |
| t = 90 | .09 | .11 | .15 | – | – | – |
| t = 180 | .13 | .16 | .19 | .34 | .39 | .44 |
| t = 270 | .16 | .19 | .24 | – | – | – |
| t = 360 | .20 | .25 | .30 | .35 | .40 | .45 |